Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy.

@article{Gursu2014UseOO,
  title={Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy.},
  author={Hazım Alper Gursu and Birgul Varan and Ilkay Erdoğan},
  journal={Cardiology in the young},
  year={2014},
  volume={24 4},
  pages={764-6}
}
A 7-year-old male patient who had abdominal swelling and eyelid oedema was diagnosed with restrictive cardiomyopathy. His serum albumin level was 2.3 g/dl. Protein-losing enteropathy due to restrictive cardiomyopathy was diagnosed and oral budesonide was started. His serum albumin level began to rise and ascites and peripheric oedema disappeared. The patient underwent a successful cardiac transplantation and budesonide was stopped. After the heart transplantation, the albumin level decreased to… CONTINUE READING